Managing Immunotherapy Toxicities

Learning Objectives

1.)      Review mechanism of PD-1/PD-L1 therapies in cancer treatment

2.)      Describe common and serious adverse events of PD-1/PD-L1 therapies

3.)      Explain the role of steroids and other management strategies in PD-1/PD-L1 therapy toxicity

4.)      Summarize treatment considerations with prolonged immunosuppression

Course summary
Available credit: 
  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Registration Opens: 
09/14/2021
Registration Expires: 
01/15/2023
Rating: 
0

Available Credit

  • 1.00 ACPE - Pharmacist
  • 1.00 ACPE - Pharmacy Technician
  • 1.00 AMA PRA Category 1 Credit(s)
  • 1.00 ANCC
  • 1.00 Attendance
  • 1.00 JA Credit - AH
    • 1.00 Approved for AMA PRA Category 1 Credit(s)
Please login or register to take this course.